CLVS - Clovis Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue95,38855,51178-
Cost of Revenue19,44410,25170-
Gross Profit75,94445,2608-
Operating Expenses
Research Development231,347142,498251,129269,251
Selling General and Administrative175,781138,90740,73130,524
Non Recurring----
Others----
Total Operating Expenses429,202293,142291,930299,775
Operating Income or Loss-333,814-237,631-291,852-299,775
Income from Continuing Operations
Total Other Income/Expenses Net-33,587-112,344-89,319-82,162
Earnings Before Interest and Taxes-333,814-237,631-291,852-299,775
Interest Expense-13,183-10,428-8,491-8,372
Income Before Tax-367,401-349,975-381,171-381,937
Income Tax Expense608-3,578-32,034-29,076
Minority Interest----
Net Income From Continuing Ops-368,009-346,397-349,137-352,861
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-368,009-346,397-349,137-352,861
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-368,009-346,397-349,137-352,861